“…A recent meta-analysis and systematic review estimated the incidence of progression (to HGD or EAC) in LGD to be 0.54 to 1.73 % per year [42]. This was limited by substantial heterogeneity in the studies and the varying natural history of LGD in different studies.…”
Section: A C C E P T E D Accepted Manuscriptmentioning
“…A recent meta-analysis and systematic review estimated the incidence of progression (to HGD or EAC) in LGD to be 0.54 to 1.73 % per year [42]. This was limited by substantial heterogeneity in the studies and the varying natural history of LGD in different studies.…”
Section: A C C E P T E D Accepted Manuscriptmentioning
“…Singh et al 1 have written a comprehensive review of Barrett's esophagus containing low-grade dysplasia, but they appear to have misinterpreted some of their own data. They state that they "were unable to identify a high-risk subset of patients with low-grade dysplasia who were likely to progress to cancer," but that is in fact not the case.…”
Section: Esophagus With Low-grade Dysplasiamentioning
confidence: 99%
“…The meta-analysis by Singh et al, 1 which is a mix of mostly unconfirmed low-grade dysplasia studies and a minority of studies with confirmed cases, almost certainly includes large numbers of patients who did not actually have low-grade dysplasia. This is a major flaw of the study and renders the conclusions unreliable.…”
Section: Esophagus With Low-grade Dysplasiamentioning
“…A more recent meta-analysis from 2014 analyzed the incidence of EAC and high-grade dysplasia in Barrett's esophagus patients with low-grade dysplasia [ 22 ]. The annual incidence of EAC was 0.54 % (95 % CI: 0.32-0.76).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.